Articles By Anuja Singh
Could GSK’s Twice-Yearly Asthma Drug Change Long-Term Treatment for Patients?
United States GlaxoSmithKline (GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved its new…
Inductive Bio and Amgen Collaborate With ARPA-H to Advance AI-Based Alternatives to Animal Toxicology…
United States Inductive Bio, a New York–based artificial intelligence company focused on drug discovery, has been awarded up…
Amgen Takes Steps With U.S. Government to Reduce Prescription Drug Costs for American Patients
Thousand Oaks, California Amgen announced that it is working with the U.S. government on new measures aimed at…
Could CagriSema Become the First Once-Weekly GLP-1 and Amylin Combination Approved by the FDA?
United States / Denmark Novo Nordisk has submitted a New Drug Application to the U.S. Food and Drug…
U.S. FDA Awards National Priority Review Vouchers to Merck for Cholesterol and Cancer Drug…
United States — The U.S. Food and Drug Administration (FDA) has awarded Commissioner’s National Priority Review Vouchers to…
Pfizer Provides 2026 Financial Guidance and Updates 2025 Revenue Outlook
New York, NY – Pfizer Inc. (NYSE: PFE) today announced its financial guidance for the full year 2026…

Could GSK’s Twice-Yearly Asthma Drug Change Long-Term Treatment for Patients?
United States GlaxoSmithKline (GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved its new…
Inductive Bio and Amgen Collaborate With ARPA-H to Advance AI-Based Alternatives to Animal Toxicology…
United States Inductive Bio, a New York–based artificial intelligence company focused on drug discovery, has been awarded up…
Amgen Takes Steps With U.S. Government to Reduce Prescription Drug Costs for American Patients
Thousand Oaks, California Amgen announced that it is working with the U.S. government on new measures aimed at…
Could CagriSema Become the First Once-Weekly GLP-1 and Amylin Combination Approved by the FDA?
United States / Denmark Novo Nordisk has submitted a New Drug Application to the U.S. Food and Drug…
U.S. FDA Awards National Priority Review Vouchers to Merck for Cholesterol and Cancer Drug…
United States — The U.S. Food and Drug Administration (FDA) has awarded Commissioner’s National Priority Review Vouchers to…
Pfizer Provides 2026 Financial Guidance and Updates 2025 Revenue Outlook
New York, NY – Pfizer Inc. (NYSE: PFE) today announced its financial guidance for the full year 2026…

